<DOC>
	<DOCNO>NCT02936115</DOCNO>
	<brief_summary>The purpose study compare clinical outcome TruSkin® Active Comparator patient chronic diabetic foot ulcer .</brief_summary>
	<brief_title>TruSkin® : Study Treatment Chronic Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Between 18 year 80 year age inclusive , date screen 2 . Confirmed diagnosis Type 1 Type 2 Diabetes 3 . An Index Ulcer chronic ( defined present &gt; 4 week , present 52 week Screening Visit ) 4 . Index Ulcer locate malleolus 5 . The Index Ulcer Diabetic Foot Ulcer ( DFU ) great 3 cm2 , inclusive , Screening Visit 6 . The long length long width measurement Index Ulcer le 1 cm Screening Visit 7 . The Index Ulcer extend dermis subcutaneous tissue without evidence expose muscle , tendon , bone , joint capsule 8 . Wound free necrotic debris 9 . Patient adequate circulation foot document ABI TBI 1 . Index Ulcer nondiabetic pathophysiology 2 . Gangrene present part affect foot 3 . Index Ulcer Charcot deformity 4 . Patient currently receive dialysis planning go dialysis 5 . Patient glycated hemoglobin A1c ( HbA1c ) level &gt; 12 % 6 . Chronic oral steroid use &gt; 7.5 mg daily longer 3 month time screen 7 . Patient receive IV corticosteroid , immunosuppressive cytotoxic agent time screen 8 . Requiring intravenous ( IV ) antibiotic treat index wound infection time screen 9 . Patient ulcer within 5 cm Index Ulcer identify study consideration 10 . Patient Human Immunodeficiency Virus ( HIV ) positive Acquired Immune Deficiency Syndrome ( AIDS ) 11 . Current evidence cellulitis , evidence infection include fever pu drainage wind site 12 . Current evidence osteomyelitis history osteomyelitis within 30 day screen 13 . Patient active malignancy nonmelanoma skin cancer 14 . Patient 's Index Ulcer decrease ≥ 20 % 1week screening period 15 . Patient 's random blood sugar &gt; 450 mg/dl screen 16 . Patient unable properly offload index wound part standard care 17 . Patient untreated alcohol substance abuse time screen 18 . Pregnant woman woman breastfeed 19 . Patient currently enrol participate another investigational device , drug , biological trial within 30 day screen 20 . Patient within last 30 day , currently undergo , plan wound treatment growth factor , live skin , dermal substitute advance biological therapy 21 . Patient employee , immediate family member employee , sponsor company site research staff conduct study 22 . Patients already randomize Protocol 351 center may consider screen reentry trial center , even End Study Visit 23 . Patients history poor compliance , unwillingness inability adhere requirement protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>